Table: Delta-Fly Pharma - 9-MTH parent results

Delta-Fly Pharma

14/02/2023 06:10

Feb 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Dec 31, 2022        Dec 31, 2021       Mar 31, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales                                100 mln           300 mln     
                (-100.0 pct)         (+0.0 pct)         (+0.0 pct)   
  Operating       loss 1.03         loss 832 mln        loss 1.15    
  Recurring       loss 1.04         loss 835 mln        loss 1.15    
  Net             loss 1.04         loss 837 mln        loss 1.15    
  EPS          loss 190.18 yen     loss 154.65 yen   loss 212.20 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T